Some may need a short course, while others might require prolonged treatment
Heres a breakdown of the dosing and findings from this trial [12]: The participants in the three groups (cagrilintide + semaglutide, semaglutide alone, and cagrilintide alone) followed a dosing regimen that involved increasing the dosage every four weeks, starting from 0.25 mg and moving up to 0.5 mg, 1.0 mg, and 1.7 mg until reaching the final dose of 2.4 mg/week at the 16-week mark
Common Side Effects Injection site reactions Headache Flushing Mild fluid retention Metabolic and Hormonal Considerations Potential alterations in glucose metabolism Elevated IGF-1 levels Theoretical risk of promoting tumor growth in predisposed individuals Key Limitation Most safety data comes from: Pediatric GH deficiency populations Adults with endocrine disorders There is limited long-term data in healthy, high-performing athletes
Alternate between right and left, and experiment with popular points for injecting vitamin B12, such as the thighs, buttocks, hips, abdomen, or upper arm